Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
| CAPS Rating |
|
|---|---|
| Open | $12.60 |
| Previous Close | $13.05 |
| Daily Range | $11.72 - $12.79 |
| 52-Week Range | $5.88 - $13.25 |
| Market Cap | $518.22M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 723,296 |
| Average Daily Volume | 0 |
ALNY
VS S&P 500 (SPY)
How do you think ALNY will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ALNY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ALNY News and Commentary
- Alnylam Pharmaceuticals Shares Dropped: What You Need to Know – The Motley Fool
- Alnylam Gets New Patent - Analyst Blog – NASDAQ
- Alnylam Riding High on RNAi Drug Delivery News – Blogs @ The Motley Fool
- Alnylam to Cut 33% Jobs - Analyst Blog – NASDAQ
- Alnylam Down to Neutral - Analyst Blog – NASDAQ
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Alnylam States Preclinical Data - Analyst Blog – NASDAQ
- Still Bullish on Alnylam - Analyst Blog – NASDAQ
- Alnylam Completes Trial Enrollment - Analyst Blog – NASDAQ
- Alnylam Reveals ALNTTR01 Trial Data - Analyst Blog – NASDAQ
- Sanofi, Regeneron's Anti-Cholesterol Drug Has Good Test Results – SmartMoney
- Hearty Profits: Companies Racing to Develop the Next Big Cholesterol Drug – NASDAQ
- 9 Small Biotechs Near 52-Week Lows – The Motley Fool
- Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment – NASDAQ
- The Biggest Gift Biotechs Can Give to Investors – The Motley Fool
- 7 Stocks That Might See a Short Squeeze – SeekingAlpha
- A Simplified ASCO 2011 List for Biotech Investor Research – SeekingAlpha
- ASCO 2011: Opportunities for Biotech Investor Success and Failure – SeekingAlpha
- 6 Cash Rich Biotech Stocks With Catalysts – SeekingAlpha
- The GBMB in review, part I – Blog at The Motley Fool
RSS Headlines
Fool UK
